SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001851734-22-000475
Filing Date
2022-08-22
Accepted
2022-08-19 18:55:05
Documents
10
Period of Report
2022-10-14

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A vtgn20220818_pre14a.htm PRE 14A 820915
2 curley.jpg GRAPHIC 5343
3 new_vtgn.jpg GRAPHIC 7723
4 vtgn20220818_pre14aimg002.jpg GRAPHIC 5379
5 vtgn20220818_pre14aimg005.jpg GRAPHIC 6148
6 vtgn20220818_pre14aimg006.jpg GRAPHIC 7337
7 vtgn20220818_pre14aimg008.jpg GRAPHIC 5995
8 vtgn20220818_pre14aimg009.jpg GRAPHIC 5259
9 vtgn20220818_pre14aimg010.jpg GRAPHIC 5694
10 vtgn20220818_pre14aimg011.jpg GRAPHIC 5379
  Complete submission text file 0001851734-22-000475.txt   898045
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: PRE 14A | Act: 34 | File No.: 001-37761 | Film No.: 221181839
SIC: 2834 Pharmaceutical Preparations